The application of artificial intelligence (AI) in oncology is still in its infancy, even though the advantages of AI could extend to numerous areas, including clinical trial matching, therapeutic decision-making, and patient outcomes.
Drs. Neeraj Agarwal and Jeanny Aragon-Ching discuss promising combination therapies and other compelling advances in genitourinary cancers in advance of the 2024 ASCO Annual Meeting.
Drs. Diwakar Davar and Jason Luke discuss key abstracts from the 2024 ASCO Annual Meeting that explore triplet therapy in advanced melanoma, TIL cell therapy…
An update to the ASCO and ONS antineoplastic therapy administration safety standards aims to confront the changing ways that such therapy is given, address the…
Drs. Vamsi Velcheti and Nathan Pennell discuss key lung cancer abstracts from the 2024 ASCO Annual Meeting, including data from LUMINOSITY and ADAURA, novel therapies…
Published online ahead of print May 22, 2024, DOI: 10.1200/OP.24.00216 Robert D. Siegel, Kristine B. LeFebvre, Sarah Temin, Amy Evers, Lisa Barbarotta, Ronda M. Bowman, Alexandre Chan,…
New research suggests the HPV vaccine is preventing cancers in men, as well as in women. The vaccine is credited, along with screening, for lowering…
Most younger women who were diagnosed with breast cancer were successful in getting pregnant, according to a new study.
Drs. Allison Zibelli and Megan Kruse discuss the potential benefit of endocrine therapy in ER-low breast cancer; the efficacy and tolerability of triplet therapy in…
1 – 20 out of 5887 Results for “2024 ASCO Annual Meeting” 5887 Results Select All Presenter: Jens Hoeppner, FAChirg, FACS, MD Presenter: Christian U.…
An update to the ASCO and ONS antineoplastic therapy administration safety standards aims to confront the changing ways that such therapy is given, address the…
